Milestone Pharmaceuticals (MIST) vs OnKure Therapeutics (OKUR)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
OnKure Therapeutics (OKUR) has outperformed Milestone Pharmaceuticals (MIST) over the past year, losing 21.4% versus a loss of 63.6%. Over five years, MIST leads with a -87.2% price change compared with -96.4% for OKUR. OnKure Therapeutics is the larger company by market cap ($93.1 million vs $88.7 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | MIST | OKUR |
|---|---|---|
| Share price | $0.7121 | $2.30 |
| Market cap | $88.66M | $93.14M |
| 1-day change | -5.96% | -2.13% |
| YTD return | -62.51% | -18.97% |
| 1-year return | -63.60% | -21.40% |
| 5-year return | -87.17% | -96.35% |
| EPS (TTM) | $-0.68 | $-3.04 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $3.06 | $5.38 |
| 52-week low | $0.7096 | $2.13 |
| Distance from 52-week high | -76.73% | -57.25% |
| Average volume | 1.39M | 211.44K |
| Shares outstanding | 124.50M | 40.50M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- OKUR has outperformed MIST by 42.2 percentage points over the past year.
MIST vs OKUR FAQ
Which is bigger, Milestone Pharmaceuticals or OnKure Therapeutics?
OnKure Therapeutics (OKUR) is larger, with a market capitalization of $93.14M compared with $88.66M for Milestone Pharmaceuticals (MIST).
Which stock has performed better over the past year, MIST or OKUR?
OKUR returned -21.40% over the past 12 months, compared with -63.60% for MIST (price return, excluding dividends). Past performance does not predict future results.
Are Milestone Pharmaceuticals and OnKure Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.